Anthony W. Opipari
Fondateur chez First Wave Bio, Inc.
Postes actifs de Anthony W. Opipari
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
First Wave Bio, Inc.
 First Wave Bio, Inc. Miscellaneous Commercial ServicesCommercial Services First Wave Bio, Inc. develops novel therapeutics for the treatment of inflammatory bowel disease. The company was founded by Gary D. Glick, Anthony W. Opipari, Luigi Franchi in 2015 and is headquartered in New York, NY. | Directeur Technique/Scientifique/R&D | 01/01/2015 | - |
| Fondateur | 01/01/2015 | - |
Historique de carrière de Anthony W. Opipari
Anciens postes connus de Anthony W. Opipari
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
IFM Therapeutics LLC
 IFM Therapeutics LLC Pharmaceuticals: MajorHealth Technology IFM Therapeutics LLC engages in the development and transformation of immunotherapy for patients with serious diseases. It focuses on developing small molecule drugs that target the innate immune system. The company was founded by Gary D. Glick, Luigi Franchi, Matthias Geyer, Eicke Latz, and Anthony W. Opipari, Jr. in 2015 and is headquartered in Boston, MA. | Fondateur | 01/01/2015 | - |
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Founder | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
IFM Therapeutics LLC
IFM Therapeutics LLC Pharmaceuticals: MajorHealth Technology IFM Therapeutics LLC engages in the development and transformation of immunotherapy for patients with serious diseases. It focuses on developing small molecule drugs that target the innate immune system. The company was founded by Gary D. Glick, Luigi Franchi, Matthias Geyer, Eicke Latz, and Anthony W. Opipari, Jr. in 2015 and is headquartered in Boston, MA. | Health Technology |
First Wave Bio, Inc.
First Wave Bio, Inc. Miscellaneous Commercial ServicesCommercial Services First Wave Bio, Inc. develops novel therapeutics for the treatment of inflammatory bowel disease. The company was founded by Gary D. Glick, Anthony W. Opipari, Luigi Franchi in 2015 and is headquartered in New York, NY. | Commercial Services |
- Bourse
- Insiders
- Anthony W. Opipari
- Expérience
